Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > NEW PLAYER ON THE MUSICAL RIDE
View:
Post by ISAloser247 on Dec 19, 2011 3:29pm

NEW PLAYER ON THE MUSICAL RIDE

...didn't this happen with PALADIN'S "not enough bandwidth" Mr. Goodman ,abandoning the board after one year of investment? Seems only natural for Dr. Foster to appoint a lawyer, as he "spends 99% of his time" with them anyway!An HONEST, MORALLY UPSTANDING-FULL OF INTEGRITY individual can never be 'too lawyered up'!another year, more unproductive waste! hey, at least SNOWFIELD DEVELOPMENTSis back trading, at .075 cents, almost in ISA'S PHASE III biotech levels, bromley isback, antonanus is gone, two-face, thrumud, krack are saving this board from the evildoers,and most importantly--the executive cheques aren't bouncing at ISA. IT WARMS THE 'CACKLES' OF MY DISEASED HEART>
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities